While countries around the globe have long been working towards modernising healthcare systems and infrastructure, Covid-19 has put these efforts into overdrive.
In recent years, an accelerated pace of technological and scientific advances has led to new medical breakthroughs and more efficient supply chains around the globe. The implications will be far reaching and profound, creating compelling opportunities for long-term investors. China is one of the world's fastest-growing major healthcare markets with a five-year compound annual growth rate of 11%, almost triple the US rate of 4% - and these estimates do not account for the significant enhancements since the coronavirus outbreak. Ox marks the spot? Assessing the animal spirits of Chin...
To continue reading this article...
Join Investment Week for free
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes